AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

IL-12-engineered allogeneic cell vaccine prevents breast cancer.

Vaccine Weekly

| August 11, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 AUG 11 - (NewsRx.com & NewsRx.net) -- An interleukin 12-engineered allogeneic cell vaccine prevents HER-2/neu transgenic breast cancer.

According to recent research published in the journal Cancer Research, "This study evaluated the ability of cytokine-engineered allogeneic (H-2degrees) HER-2/neu-positive cells to prevent tumor development in mammary cancer-prone virgin female BALB/c (H-2[superscript]d) mice transgenic for the transforming rat HER-2/neu oncogene (BALB-neuT mice). Repeated vaccinations with cells engineered to release interleukin (IL)-2, IL-12, IL-15, or IFN-gamma showed that IL-12-engineered cell vaccines had the most powerful immunopreventive activity, with >80% of 1-year-old BALB-neuT mice free of tumors, respectively."

"On the contrary, all of the untreated mice and all of the mice vaccinated with IL-12-engineered cells lacking either HER-2/neu or allogeneic antigens developed mammary carcinomas within 22 or 33 weeks," said Carla de Giovanni at the University of Bologna and collaborators throughout Italy. "Whole mount, histology, immunohistochemistry, and gene expression profile analysis showed that vaccination with IL-12-engineered cells maintained 26-week mammary glands free of neoplastic growth, with a gene expression profile that clustered with that of untreated preneoplastic glands."

"The IL-12-engineered cell vaccine elicited a high production of IFN-gamma and IL-4 and a strong anti-HER-2/neu antibody response," ...

Related articles from newspapers, magazines, journals, and more
Reports summarize bladder cancer research from National Institutes of Health.
Newspaper article from: Immunotherapy Weekly September 23, 2009 700+ words
...significantly higher than either IL-12 alone or BCG. Immunohistochemistry...macrophages following chitosan/IL-12 treatments. Bladder submucosa...Intravesical chitosan/IL-12 is a well-tolerated...colleagues published their study in Cancer Research (Intravesical Immunotherapy...
Data on gene therapy discussed by investigators at German Cancer Research...
Newspaper article from: Cancer Vaccine Week October 27, 2008 700+ words
...stimulation with rec(IL-2) infected allogeneic...cells by ATV-rec(IL-2)," wrote M. Janke and colleagues, German Cancer Research Center, Division of...disease virus producing IL-2. International Journal...contact M. Janke, German Cancer Research Center, Division of...
Cancer research advocates rally on Capitol Hill for restored funding.
Newspaper article from: Chicago Tribune (Chicago, IL) September 19, 2006 700+ words
...Congress that advances in cancer research are having tangible...issues, including for cancer research, after November's...responsible for doubling cancer research funding from 1998 to...Suite 303, Glenview, IL 60025, USA.
New cancer research from University of Toledo, Medical Department...
Newspaper article from: Cancer Weekly October 20, 2009 700+ words
...control of interleukin (IL)-1 beta promoter...writing in the journal Cancer Research report (see also Cancer...production of IL-1 beta, IL-6, and IL-12, increased surface...published their study in Cancer Research (Classification of...
Research results from Queen's University, Center for Cancer Research and Cell...
Newspaper article from: Cancer Gene Therapy Week October 6, 2008 700+ words
...antagonist to block TRAIL-and IL-8-induced up-regulation...endogenous and TRAIL-induced IL-8 signaling can modulate the...s University, Center for Cancer Research and Cell Biology (see also...Therefore, targeted inhibition of IL-8 signaling or c-FLIP expression...
New findings from Technical University Munchen, Cancer Research Center describe...
Newspaper article from: Gene Therapy Weekly September 10, 2009 700+ words
...CD40-Ligand (CD40-L), IL-9 and interferon (IFN...receptor 6 (DR6) or reversed IL-2-mediated repression of...Technical University Munchen, Cancer Research Center (see also RNA Research...of DR6 and TOSO expression in IL-2-dependent T-cell activation...
Papa John's Gives The Works(TM) To The V Foundation for Cancer Research.
Press release article from: PR Newswire June 5, 2000 700+ words
...Help Fund 40-Plus Cancer Research Grants Across the U...money donated to fund cancer research." As a part of the...the best and brightest cancer research doctors. The remaining...Medical Center, Peoria, IL Dr. Jeff Yoda, Parkview...
New data from M. Pletneva et al illuminate research in cancer research.
Newspaper article from: Cancer Weekly October 6, 2009 700+ words
...research published in the journal Cancer Research, "IFN-producing killer dendritic...type 1 and 2 IFNs, interleukin (IL)+12, natural killing, and ultimately...Pletneva and colleagues (see also Cancer Research). The researchers concluded...
For more facts and information, see all results

Source: HighBeam Research, IL-12-engineered allogeneic cell vaccine prevents breast cancer.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA